Penequinine, Penehyclidine

DB16287InvestigationalSmall molecule

Penequinine, Penehyclidine is under investigation in clinical trial NCT02644876 (Preventive Effects of Penehyclidine Hydrochloride Inhalation on Postoperative Pulmonary Complications).

Mechanism: Pharmacologically active on Muscarinic acetylcholine receptor M3 and Muscarinic acetylcholine receptor M1
Curator reviewed
Formula / weight: C₂₀H₂₉NO₂ · 315.457 g/mol (avg)
Also known as: Penehyclidine · Penequine · Penequinine · Penethequinine
Code names: M-8218 · P8018

Resolves to

Compound

UNII353CX8CSHDCAS87827-02-9

Structure

InChIKeyGTKRIWMDLNOSLI-UHFFFAOYSA-NSMILESOC(COC1CN2CCC1CC2)(C1CCCC1)C1=CC=CC=C1

Targets

P20309CHRM3P11229CHRM1

What you can answer from here — as of July 08, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

8Clinical trialsPhase, status and sponsor resolved per trial

8+ReferencesStructured and connected to the statements they support

Which drugs share a target with Penequinine, Penehyclidine, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account